I´ll make it simple.
1) Really promising reseachs on Alzheimer drug.
2) Atm there are 9.9MILLION new diagnoses of demencia every year(increasing market) this number is 30% more than what the worlds health organization predicted in 2010... hense the undervalue.
3) Increasing Profits
4) EPS at 4,71 higher than what many predicted.
5) Good administration.
1) Really promising reseachs on Alzheimer drug.
2) Atm there are 9.9MILLION new diagnoses of demencia every year(increasing market) this number is 30% more than what the worlds health organization predicted in 2010... hense the undervalue.
3) Increasing Profits
4) EPS at 4,71 higher than what many predicted.
5) Good administration.
コメント:
hence"